• Home
• About us
• Contact

• News
• People
• Products
• Deals
• Organisations

• » Follow us on twitter!
• » Get Free Newsletter!

Advertisement

Product › Details

oncolytic virus (cancer-cilling virus, virotherapy for cancer, virus-based cancer therapy)

	Next higher product group	cancer drug
	Status	2006-06-08 development existent
	Organisation	Medigene AG (FSE: MDG1, Prime Standard)
	Group	Medigene (Group)

Record changed: 2021-03-23

Advertisement

More documents for oncolytic virus (cancer-cilling virus, virotherapy for cancer, virus-based cancer therapy)

• [1] Elicera Therapeutics AB. (1/11/21). "Press Release: Elicera Therapeutics Recruits CFO [ Elicera Therapeutics rekryterar CFO ]". Uppsala....
• [2] Boehringer Ingelheim. (12/9/20). "Press Release: Boehringer Ingelheim to Acquire Labor Dr. Merk & Kollegen to Strengthen its Next Generation Cancer Immunology Program". Ingelheim & Ochsenhausen....
• [3] Transgene S.A.. (12/3/20). "Press Release: Transgene Appoints Hedi Ben Brahim as Chairman and Chief Executive Officer". Strasbourg....
• [4] Valo Therapeutics Ltd.. (8/3/20). "Press Release: Valo Therapeutics Appoints Industry Veteran Paul G Higham as CEO". Oxford & Helsinki....
• [5] Valo Therapeutics Ltd.. (6/8/20). "Press Release: Valo Therapeutics Announces Board Appointment of Dr Mai-Britt Zocca". Oxford & Helsinki....
• [6] Abalos Therapeutics GmbH. (10/15/19). "Press Release: Abalos Therapeutics Launches with €12M Series A Round to Develop Novel Immuno-Virotherapies Against Cancer". Essen....
• [7] Oncorus, Inc.. (8/21/19). "Press Release: Oncorus Announces $79.5 Million Series B Financing Co-Led by Cowen Healthcare Investments and Perceptive Advisors". Cambridge, MA....
• [8] Oncovita S.A.S.. (7/2/19). "Press Release: Oncovita Signs Exclusive Licensing Agreement with Institut Pasteur. Agreement Will Cover Development and Marketing of Oncolytic Virotherapies". Paris....
• [9] Transgene S.A.. (7/2/19). "Press Release: Success of Transgene’s €48.7 Million Rights Issue [This document must not be distributed, directly or indirectly, in the United States of America, Australia, Canada or Japan]". Strasbourg....
• [10] Transgene S.A.. (6/14/19). "Press Release: Transgene Launches a Rights Issue for an Amount of up to €50 Million [This document must not be distributed, directly or indirectly, in the United States of America, Australia, Canada or Japan]". Strasbourg....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2021. Made in Germany.